Reported Aug 3, 2016 · Terminated

Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles, Rx Only Manufactured by: Actavis…

Actavis Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Actavis Inc · 400 Interpace Pkwy · Parsippany, NJ · 07054-1120

Is this the product you have?

  • Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles
  • Rx Only Manufactured byActavis Elizabeth LLC Elizabeth, NJ 07207 USA
  • Distributed byActavis Pharma, Inc Parsippany, NJ 07054 USA NDC 45963-304-09
Lot codes and dates
    • Lot #: 3803J141
    • Exp. 7/2016
Amount recalled
8,062 units

Where it was sold

  • Nationwide

Why it was recalled

Failed Dissolution Specifications

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Actavis Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Feb 16, 2017 · Data as of Sep 19, 6:29 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.